Large-scale genomics unveils the genetic architecture of psychiatric disorders

Family study results are consistent with genetic effects making substantial contributions to risk of psychiatric disorders such as schizophrenia, yet robust identification of specific genetic variants that explain variation in population risk had been disappointing until the advent of technologies that assay the entire genome in large samples. We highlight recent progress that has led to a better understanding of the number of risk variants in the population and the interaction of allele frequency and effect size. The emerging genetic architecture implies a large number of contributing loci (that is, a high genome-wide mutational target) and suggests that genetic risk of psychiatric disorders involves the combined effects of many common variants of small effect, as well as rare and de novo variants of large effect. The capture of a substantial proportion of genetic risk facilitates new study designs to investigate the combined effects of genes and the environment.

[1]  Major Depressive,et al.  A mega-analysis of genome-wide association studies for major depressive disorder , 2016 .

[2]  M. Daly,et al.  Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis , 2013, The Lancet.

[3]  Kenny Q. Ye,et al.  Strong Association of De Novo Copy Number Mutations with Autism , 2007, Science.

[4]  Alexander Hoischen,et al.  Prioritization of neurodevelopmental disease genes by discovery of new mutations , 2014, Nature Neuroscience.

[5]  R. Handsaker,et al.  Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder , 2012, Molecular Psychiatry.

[6]  C. Gillberg,et al.  The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. , 2010, The American journal of psychiatry.

[7]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[8]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[9]  J. Sebat,et al.  High Frequencies of De Novo CNVs in Bipolar Disorder and Schizophrenia , 2011, Neuron.

[10]  Kenny Q. Ye,et al.  De Novo Gene Disruptions in Children on the Autistic Spectrum , 2012, Neuron.

[11]  Alan S. Brown,et al.  Aberrant epigenetic regulation could explain the relationship of paternal age to schizophrenia. , 2006, Schizophrenia bulletin.

[12]  M. Swash,et al.  Controversies and priorities in amyotrophic lateral sclerosis , 2013, The Lancet Neurology.

[13]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[14]  Esben Agerbo,et al.  Bipolar disorder, schizoaffective disorder, and schizophrenia overlap: a new comorbidity index. , 2009, The Journal of clinical psychiatry.

[15]  Benjamin D. Greenberg,et al.  Partitioning the Heritability of Tourette Syndrome and Obsessive Compulsive Disorder Reveals Differences in Genetic Architecture , 2013, PLoS genetics.

[16]  K. Kendler,et al.  Incidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in Sweden. , 2013, Schizophrenia bulletin.

[17]  H. Hakonarson,et al.  A genome-wide association study on common SNPs and rare CNVs in anorexia nervosa , 2011, Molecular Psychiatry.

[18]  真田 昌.  骨髄異形成症候群のgenome-wide analysis , 2013 .

[19]  P. Sullivan,et al.  Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. , 2003, Archives of general psychiatry.

[20]  Jun S. Liu,et al.  Genetics of rheumatoid arthritis contributes to biology and drug discovery , 2013 .

[21]  Neda Jahanshad,et al.  Whole-genome analyses of whole-brain data: working within an expanded search space , 2014, Nature Neuroscience.

[22]  L. Cardon,et al.  Use of genome-wide association studies for drug repositioning , 2012, Nature Biotechnology.

[23]  J. Sebat,et al.  Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia , 2011, Nature.

[24]  N. Craddock,et al.  Genome-wide association studies: a primer , 2009, Psychological Medicine.

[25]  Tanya M. Teslovich,et al.  Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes , 2012, Nature Genetics.

[26]  J. Barendregt,et al.  Global burden of disease , 1997, The Lancet.

[27]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[28]  Guoping Feng,et al.  Genome-scale neurogenetics: methodology and meaning , 2014, Nature Neuroscience.

[29]  Jianxin Shi,et al.  Common variants on chromosome 6p22.1 are associated with schizophrenia , 2009, Nature.

[30]  P. Visscher,et al.  Where GWAS and epidemiology meet: opportunities for the simultaneous study of genetic and environmental risk factors in schizophrenia. , 2013, Schizophrenia bulletin.

[31]  P. Visscher,et al.  Five years of GWAS discovery. , 2012, American journal of human genetics.

[32]  L. Petersen,et al.  A comprehensive assessment of parental age and psychiatric disorders. , 2014, JAMA psychiatry.

[33]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[34]  T. Insel,et al.  Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? , 2012, Molecular Psychiatry.

[35]  M. Keshavan.  Faculty Opinions recommendation of Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. , 2014 .

[36]  Kathryn Roeder,et al.  Analysis of Rare, Exonic Variation amongst Subjects with Autism Spectrum Disorders and Population Controls , 2013, PLoS genetics.

[37]  P M Visscher,et al.  Evidence-based psychiatric genetics, AKA the false dichotomy between common and rare variant hypotheses , 2012, Molecular Psychiatry.

[38]  B. Crespi,et al.  Comparative genomics of autism and schizophrenia , 2010, Proceedings of the National Academy of Sciences.

[39]  M. Daly,et al.  Estimation of the multiple testing burden for genomewide association studies of nearly all common variants , 2008, Genetic epidemiology.

[40]  D. Altshuler,et al.  Validating therapeutic targets through human genetics , 2013, Nature Reviews Drug Discovery.

[41]  Jianxin Shi,et al.  Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs , 2013, Nature Genetics.

[42]  W. G. Hill,et al.  Data and Theory Point to Mainly Additive Genetic Variance for Complex Traits , 2008, PLoS genetics.

[43]  Michael F. Walker,et al.  De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.

[44]  S. Levy,et al.  De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia , 2012, Nature Genetics.

[45]  P. Visscher,et al.  Additive genetic variation in schizophrenia risk is shared by populations of African and European descent. , 2013, American journal of human genetics.

[46]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[47]  鮫島 浩,et al.  Population-based study からみた神経予後不良因子の検討 , 2009 .

[48]  Susanne Walitza,et al.  Genome-Wide Analysis of Copy Number Variants in Attention Deficit Hyperactivity Disorder: The Role of Rare Variants and Duplications at 15q13.3 , 2012, The American journal of psychiatry.

[49]  E. Banks,et al.  De novo mutations in schizophrenia implicate synaptic networks , 2014, Nature.

[50]  A. Eyre-Walker.  Evolution in health and medicine Sackler colloquium: Genetic architecture of a complex trait and its implications for fitness and genome-wide association studies. , 2010, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Matthew C Keller,et al.  A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry. , 2011, The American journal of psychiatry.

[52]  H. Stefánsson,et al.  Supplementary webappendix , 2018 .

[53]  P. Visscher,et al.  Interpreting the role of de novo protein-coding mutations in neuropsychiatric disease , 2013, Nature Genetics.

[54]  Jianxin Shi,et al.  Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. , 2011, The American journal of psychiatry.

[55]  Jun Li,et al.  Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: Genome‐wide association study of both common and rare variants , 2013, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[56]  M. King,et al.  Genetic Heterogeneity in Human Disease , 2010, Cell.

[57]  Naomi R. Wray,et al.  Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis , 2012, Human molecular genetics.

[58]  R. Reading,et al.  Diagnostic exome sequencing in persons with severe intellectual disability , 2013 .

[59]  Boris Yamrom,et al.  Rare De Novo and Transmitted Copy-Number Variation in Autistic Spectrum Disorders , 2011, Neuron.

[60]  Bok-Ghee Han,et al.  Ubiquitous Polygenicity of Human Complex Traits: Genome-Wide Analysis of 49 Traits in Koreans , 2013, PLoS genetics.

[61]  Ayellet V. Segrè,et al.  Hundreds of variants clustered in genomic loci and biological pathways affect human height , 2010, Nature.

[62]  M. Lynch,et al.  Genetics and Analysis of Quantitative Traits , 1996 .

[63]  Bradley P. Coe,et al.  Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations , 2012, Nature.

[64]  P. Visscher,et al.  Sporadic cases are the norm for complex disease , 2010, European Journal of Human Genetics.

[65]  Eric S. Lander,et al.  A polygenic burden of rare disruptive mutations in schizophrenia , 2014, Nature.

[66]  M. Daly,et al.  Case-control genome-wide association study of attention-deficit/hyperactivity disorder. , 2010, Journal of the American Academy of Child and Adolescent Psychiatry.

[67]  T. Suppes,et al.  Dimensions and the psychosis phenotype , 2007, International journal of methods in psychiatric research.

[68]  G. Miller,et al.  Resolving the paradox of common, harmful, heritable mental disorders: which evolutionary genetic models work best? , 2006, The Behavioral and brain sciences.

[69]  Joseph A. Gogos,et al.  Strong association of de novo copy number mutations with sporadic schizophrenia , 2008, Nature Genetics.

[70]  Anders D. Børglum,et al.  Genome-wide association study identifies five new schizophrenia loci , 2011, Nature Genetics.

[71]  Michael Wigler,et al.  Rare De Novo Variants Associated with Autism Implicate a Large Functional Network of Genes Involved in Formation and Function of Synapses , 2011, Neuron.

[72]  N. Wray,et al.  Impact of diagnostic misclassification on estimation of genetic correlations using genome-wide genotypes , 2012, European Journal of Human Genetics.

[73]  L. DeLisi,et al.  Selected rapporteur summaries from the XX world congress of psychiatric genetics, Hamburg, Germany, october 14–18, 2012 , 2013, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[74]  Vladimir Makarov,et al.  Scan statistic-based analysis of exome sequencing data identifies FAN1 at 15q13.3 as a susceptibility gene for schizophrenia and autism , 2013, Proceedings of the National Academy of Sciences.

[75]  K. Kendler,et al.  The risk for psychiatric disorders in relatives of schizophrenic and control probands: a comparison of three independent studies , 1997, Psychological Medicine.

[76]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[77]  Christian Gilissen,et al.  Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, New England Journal of Medicine.

[78]  Lilia M. Iakoucheva,et al.  Whole-Genome Sequencing in Autism Identifies Hot Spots for De Novo Germline Mutation , 2012, Cell.

[79]  N. Wray,et al.  Using Summary Data from the Danish National Registers to Estimate Heritabilities for Schizophrenia, Bipolar Disorder, and Major Depressive Disorder , 2012, Front. Gene..

[80]  M. Owen,et al.  Genetics of schizophrenia , 2005, Current Opinion in Behavioral Sciences.

[81]  L. Petersen,et al.  Paternal age at birth of first child and risk of schizophrenia. , 2011, The American journal of psychiatry.

[82]  J. Sebat,et al.  Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. , 2009, Trends in genetics : TIG.

[83]  Simon C. Potter,et al.  Genome-wide Association Analysis Identifies 14 New Risk Loci for Schizophrenia , 2013, Nature Genetics.

[84]  R. Kotov,et al.  Diagnostic shifts during the decade following first admission for psychosis. , 2011, The American journal of psychiatry.

[85]  Tyrone D. Cannon,et al.  Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study , 2009, The Lancet.

[86]  P. Visscher,et al.  Common SNPs explain a large proportion of heritability for human height , 2011 .

[87]  Evan T. Geller,et al.  Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.

[88]  N. Wray,et al.  Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned , 2010, Molecular Psychiatry.

[89]  Patrick F Sullivan,et al.  The Psychiatric GWAS Consortium: Big Science Comes to Psychiatry , 2010, Neuron.

[90]  P. Visscher,et al.  Estimating missing heritability for disease from genome-wide association studies. , 2011, American journal of human genetics.

[91]  Sang Hong Lee,et al.  Estimation of pleiotropy between complex diseases using single-nucleotide polymorphism-derived genomic relationships and restricted maximum likelihood , 2012, Bioinform..

[92]  Ryan S. Lee,et al.  Linking the SWI/SNF complex to prostate cancer , 2013, Nature Genetics.

[93]  Kathryn Roeder,et al.  Multiple Recurrent De Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism , 2011, Neuron.

[94]  Angelica Ronald,et al.  Autism spectrum disorders and autistic traits: A decade of new twin studies , 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[95]  S Purcell,et al.  De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia , 2011, Molecular Psychiatry.

[96]  Patrick F. Sullivan,et al.  Don't give up on GWAS , 2012, Molecular Psychiatry.